{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:47:08Z","timestamp":1780109228917,"version":"3.54.0"},"reference-count":26,"publisher":"BMJ","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2012,8,6]]},"published-print":{"date-parts":[[2012]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the prevalence of microalbuminuria and kidney dysfunction in low-income countries and in the USA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cross-sectional study of screening programmes in five countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Screening programmes in Nepal, Bolivia, the USA (National Health and Nutrition Examination Survey (NHANES) 2005\u20132008) Bangladesh and Georgia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>General population in Nepal (n=20\u2005811), Bolivia (n=3436) and in the USA (n=4299) and high-risk subjects in Bangladesh (n=1518) and Georgia (n=1549).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>\n                      Estimated glomerular filtration rate (eGFR)&lt;60ml\/min\/1.73\u2005m\n                      <jats:sup>2<\/jats:sup>\n                      and microalbuminuria (defined as urinary albumin creatinine ratio values of 30\u2013300\u2005mg\/g) were the main outcome measures. The cardiovascular (CV) risk was also evaluated on the basis of demographic, clinical and blood data.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The prevalence of eGFR&lt;60ml\/min\/1.73\u2005m\n                      <jats:sup>2<\/jats:sup>\n                      was 19%, 3.2% and 7% in Nepal, Bolivia and the USA, respectively. In Nepal, 7% of subjects were microalbuminuric compared to 8.6% in the USA. The prevalence of participants with predicted 10-year CV disease (CVD) risk \u226510% was 16.9%, 9.4% and 17% in Nepal, Bolivia and in the USA, respectively. In Bangladesh and Georgia, subjects with eGFR&lt;60\u2005ml\/min\/1.73\u2005m\n                      <jats:sup>2<\/jats:sup>\n                      were 8.6% and 4.9%, whereas those with microalbuminuria were 45.4% and 56.5%, respectively. Predicted 10-year CVD risk \u226510% was 25.4% and 25% in Bangladesh and Georgia, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Renal abnormalities are common among low-income countries and in the USA. Prevention programmes, particularly focused on those with renal abnormalities, should be established worldwide to prevent CVD and progression to end-stage renal disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2012-001357","type":"journal-article","created":{"date-parts":[[2012,9,22]],"date-time":"2012-09-22T21:40:06Z","timestamp":1348350006000},"page":"e001357","source":"Crossref","is-referenced-by-count":30,"title":["Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA"],"prefix":"10.1136","volume":"2","author":[{"given":"Paolo","family":"Cravedi","sequence":"first","affiliation":[{"name":"1Clinical Research Center for Rare Diseases \u201cAldo e Cele Dacc\u00f2\u201d, Villa Camozzi, Ranica, and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Mario Negri Institute for Pharmacological Research, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjib Kumar","family":"Sharma","sequence":"additional","affiliation":[{"name":"2Department of Medicine, BP Koirala Institute of Health Science, Dharan, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo Flores","family":"Bravo","sequence":"additional","affiliation":[{"name":"3Department of Medicine, Hospital Juan XXIII, La Paz, Bolivia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazmul","family":"Islam","sequence":"additional","affiliation":[{"name":"4Department of Nephrology, North East Medical College Hospital Sylhet, Sylhet, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Tchokhonelidze","sequence":"additional","affiliation":[{"name":"5Dialysis, Nephrology and Transplantation Union of Georgia, National Center of Urology, Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav","family":"Ghimire","sequence":"additional","affiliation":[{"name":"2Department of Medicine, BP Koirala Institute of Health Science, Dharan, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishnu","family":"Pahari","sequence":"additional","affiliation":[{"name":"2Department of Medicine, BP Koirala Institute of Health Science, Dharan, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Thapa","sequence":"additional","affiliation":[{"name":"2Department of Medicine, BP Koirala Institute of Health Science, Dharan, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Basnet","sequence":"additional","affiliation":[{"name":"2Department of Medicine, BP Koirala Institute of Health Science, Dharan, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avtandil","family":"Tataradze","sequence":"additional","affiliation":[{"name":"5Dialysis, Nephrology and Transplantation Union of Georgia, National Center of Urology, Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davitaia","family":"Tinatin","sequence":"additional","affiliation":[{"name":"6Department of Pediatrics, M. Iashvili Children Central Hospital, Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lela","family":"Beglarishvili","sequence":"additional","affiliation":[{"name":"5Dialysis, Nephrology and Transplantation Union of Georgia, National Center of Urology, Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyng-Wen","family":"Fwu","sequence":"additional","affiliation":[{"name":"7Social & Scientific Systems, Inc., Silver Spring, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B","family":"Kopp","sequence":"additional","affiliation":[{"name":"8Kidney Disease Section, NIDDK, NIH, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Eggers","sequence":"additional","affiliation":[{"name":"9Division of Kidney, Urologic and Hematologic Diseases, NIDDK, NIH, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Ene-Iordache","sequence":"additional","affiliation":[{"name":"1Clinical Research Center for Rare Diseases \u201cAldo e Cele Dacc\u00f2\u201d, Villa Camozzi, Ranica, and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Mario Negri Institute for Pharmacological Research, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Carminati","sequence":"additional","affiliation":[{"name":"1Clinical Research Center for Rare Diseases \u201cAldo e Cele Dacc\u00f2\u201d, Villa Camozzi, Ranica, and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Mario Negri Institute for Pharmacological Research, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Perna","sequence":"additional","affiliation":[{"name":"1Clinical Research Center for Rare Diseases \u201cAldo e Cele Dacc\u00f2\u201d, Villa Camozzi, Ranica, and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Mario Negri Institute for Pharmacological Research, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Chianca","sequence":"additional","affiliation":[{"name":"1Clinical Research Center for Rare Diseases \u201cAldo e Cele Dacc\u00f2\u201d, Villa Camozzi, Ranica, and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Mario Negri Institute for Pharmacological Research, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G","family":"Couser","sequence":"additional","affiliation":[{"name":"10Division of Nephrology, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[{"name":"1Clinical Research Center for Rare Diseases \u201cAldo e Cele Dacc\u00f2\u201d, Villa Camozzi, Ranica, and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Mario Negri Institute for Pharmacological Research, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto","family":"Perico","sequence":"additional","affiliation":[{"name":"1Clinical Research Center for Rare Diseases \u201cAldo e Cele Dacc\u00f2\u201d, Villa Camozzi, Ranica, and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Mario Negri Institute for Pharmacological Research, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2012,9,22]]},"reference":[{"key":"2025121511004341000_2.5.e001357.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi880"},{"key":"2025121511004341000_2.5.e001357.2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000031732.78052.81"},{"key":"2025121511004341000_2.5.e001357.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60674-5"},{"key":"2025121511004341000_2.5.e001357.4","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000139860.33974.28"},{"key":"2025121511004341000_2.5.e001357.5","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001729"},{"key":"2025121511004341000_2.5.e001357.6","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.5.1047"},{"key":"2025121511004341000_2.5.e001357.7","unstructured":"The Seventh Report of the Joint National Committee on Prevention D, Evaluation, and Treatment of High Blood Pressure\u2014Complete Report. http:\/\/www.nhlbi.nih.gov\/guidelines\/hypertension\/jnc7full.htm (accessed 7 Jun 2011)."},{"key":"2025121511004341000_2.5.e001357.8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00002"},{"key":"2025121511004341000_2.5.e001357.9","unstructured":"World Health Organization. Obesity: preventing and managing the global epidemic technical report series no 894. Geneva, Switzerland: World Health Organization; 2000."},{"key":"2025121511004341000_2.5.e001357.10","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-10-25"},{"key":"2025121511004341000_2.5.e001357.11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000058"},{"key":"2025121511004341000_2.5.e001357.12","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2008.605"},{"key":"2025121511004341000_2.5.e001357.13","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.07.023"},{"key":"2025121511004341000_2.5.e001357.14","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn469"},{"key":"2025121511004341000_2.5.e001357.15","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1111\/j.1523-1755.2005.09408.x","article-title":"The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population","volume":"94","author":"Gansevoort","year":"2005","journal-title":"Kidney Int Suppl"},{"key":"2025121511004341000_2.5.e001357.16","doi-asserted-by":"publisher","DOI":"10.1126\/science.1092488"},{"key":"2025121511004341000_2.5.e001357.17","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr014"},{"key":"2025121511004341000_2.5.e001357.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07493-4"},{"key":"2025121511004341000_2.5.e001357.19","unstructured":"Global status report on noncommunicable diseases 2010. Geneva: WHO. http:\/\/www.who.int\/nmh\/publications\/ncd_report_full_en.pdf (accessed 7 Feb 2012)."},{"key":"2025121511004341000_2.5.e001357.20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1595"},{"key":"2025121511004341000_2.5.e001357.21","unstructured":"2008-2013 WHO. Action plan for the global strategy for the prevention and control of noncommunicable diseases: prevent and control cardiovascular diseases, cancer, chronic respiratory diseases and diabetes. Geneva, Switzerland: WHO, 2008."},{"key":"2025121511004341000_2.5.e001357.22","doi-asserted-by":"publisher","DOI":"10.1159\/000321515"},{"key":"2025121511004341000_2.5.e001357.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2010.01309.x"},{"key":"2025121511004341000_2.5.e001357.24","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.06.022"},{"key":"2025121511004341000_2.5.e001357.25","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/ki.2009.540","article-title":"Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) Mexico and comparison with KEEP US","volume":"116","author":"Obrador","year":"2010","journal-title":"Kidney Int Suppl"},{"key":"2025121511004341000_2.5.e001357.26","unstructured":"Kumar Sharma S . World Congress of Nephrology, Vancouver, Canada, 8\u201311 April 2011. Abstr MO311-1237 2011."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2012-001357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:00:51Z","timestamp":1765825251000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2012-001357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,9,25]]},"published-print":{"date-parts":[[2012]]}},"alternative-id":["10.1136\/bmjopen-2012-001357"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2012-001357","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}